Disclosed positions

Estimated from their latest filings — positions may have changed since

$963.1K

combined est. value

Stock	Shares	Price	Value	Weight	As of
XERSXeris Biopharma Holdings, Inc.	119,193	$8.08	$963.1K	100%	2026-06-04

XERS

Xeris Biopharma Holdings, Inc.

$963.1K

119,193 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 2

Stock	Transaction	Date	~6mo later
XERSXeris Biopharma Holdings, Inc.	Grant — · 24,193 sh	2026-06-04	—
XERSXeris Biopharma Holdings, Inc.	Sell $121.9K · 20,000 sh	2026-06-04	—
XERSXeris Biopharma Holdings, Inc.	Sell $309.2K · 42,500 sh	2025-08-12	—
XERSXeris Biopharma Holdings, Inc.	Grant — · 50,000 sh	2025-06-04	—

XERSGrant

2026-06-04 · Xeris Biopharma Holdings, Inc.

24,193

—

XERSSell

2026-06-04 · Xeris Biopharma Holdings, Inc.

$121.9K

—

XERSSell

2025-08-12 · Xeris Biopharma Holdings, Inc.

$309.2K

—

XERSGrant

2025-06-04 · Xeris Biopharma Holdings, Inc.

50,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.